C12Q2523/101

Matrix arrays and methods for making same

A method of forming a polymer matrix array includes treating a surface within a well of a well array with a surface compound including a surface reactive functional group and a radical-forming distal group; applying an aqueous solution including polymer precursors to the well of the well array; and activating the radical-forming distal group of the surface coupling compound with an initiator and atom transfer radical polymerization (ATRP) catalyst to initiate radical polymerization of the polymer precursors within the well of the well array to form the polymer matrix array.

Matrix arrays and methods for making same

A method of forming a polymer matrix array includes treating a surface within a well of a well array with a surface compound including a surface reactive functional group and a radical-forming distal group; applying an aqueous solution including polymer precursors to the well of the well array; and activating the radical-forming distal group of the surface coupling compound with an initiator and atom transfer radical polymerization (ATRP) catalyst to initiate radical polymerization of the polymer precursors within the well of the well array to form the polymer matrix array.

COMPOSITIONS AND METHODS FOR LIGHT-DIRECTED BIOMOLECULAR BARCODING

Provided herein are compositions, kits, and methods for nucleic acid barcoding. The barcode compositions provided herein can be used to linearly, combinatorially, or spatially barcode a plurality of targets in a sample. Also provided herein is a device for use in a barcoding method provided herein comprising a light source and a sample holder.

COMPOSITIONS AND METHODS FOR LIGHT-DIRECTED BIOMOLECULAR BARCODING

Provided herein are compositions, kits, and methods for nucleic acid barcoding. The barcode compositions provided herein can be used to linearly, combinatorially, or spatially barcode a plurality of targets in a sample. Also provided herein is a device for use in a barcoding method provided herein comprising a light source and a sample holder.

DETECTION OF VIABLE MICROORGANISMS IN URINE
20230022779 · 2023-01-26 ·

The present invention provides a method for the detection of viable microorganisms in urine using DNA-crosslinking agent to differentiate between dead and live microorganisms. The DNA-crosslinking agent can penetrate cells which have compromised cell membranes, such as dead cells. The method of the present application comprises amplifying DNA in the urine sample which is pre-treated with the DNA-crosslinking agent. In addition, the method includes the step of centrifugation to remove supernatant from the urine.

DETECTION OF VIABLE MICROORGANISMS IN URINE
20230022779 · 2023-01-26 ·

The present invention provides a method for the detection of viable microorganisms in urine using DNA-crosslinking agent to differentiate between dead and live microorganisms. The DNA-crosslinking agent can penetrate cells which have compromised cell membranes, such as dead cells. The method of the present application comprises amplifying DNA in the urine sample which is pre-treated with the DNA-crosslinking agent. In addition, the method includes the step of centrifugation to remove supernatant from the urine.

Multiplex Chromatin Interaction Analysis with Single-Cell Chia-Drop
20230227809 · 2023-07-20 ·

The scChIA-Drop method is a microfluidics-based dual-indexing strategy for single-cell and single-molecule chromatin interaction analysis.

Multiplex Chromatin Interaction Analysis with Single-Cell Chia-Drop
20230227809 · 2023-07-20 ·

The scChIA-Drop method is a microfluidics-based dual-indexing strategy for single-cell and single-molecule chromatin interaction analysis.

Application of epigenetic chromosomal interactions in cancer diagnostics

The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.

Application of epigenetic chromosomal interactions in cancer diagnostics

The invention provides a method of determining the epigenetic chromosome interactions which are relevant to a prognostic companion epigenetic test for cancer.